Impaired PI3 K Akt expression in liver and skeletal muscle of ovariectomized rats

Yan Wang1, Baoxin Li, Wei Zhang

  • 1Department of Endocrinology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China, wangyan0208@yahoo.cn.

Endocrine
|February 5, 2013
PubMed

Insights

Estrogen deficiency contributes to insulin resistance (IR) by impairing the PI3K/Akt signaling pathway in the liver and muscles. Estrogen therapy can reverse these effects, highlighting its role in metabolic health.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Molecular Biology

Background:

  • Estrogen deficiency is linked to insulin resistance (IR), but underlying mechanisms remain unclear.
  • Insulin resistance involves reduced insulin-stimulated PI3K/Akt signaling in key metabolic tissues.
  • Ovariectomy (OVX) is a model for studying estrogen deficiency effects.

Purpose of the Study:

  • To investigate the impact of estrogen deficiency on the PI3K/Akt signaling pathway.
  • To determine if ovariectomy in rats affects PI3K and Akt protein expression.
  • To assess the reversibility of these changes with estrogen supplementation.

Main Methods:

  • Ovariectomized (OVX) and sham-operated (SHAM) rats were used.
  • Plasma estrogen levels and HOMA-IR index were measured.
  • PI3K and Akt protein expression in liver and skeletal muscle were analyzed via Western blotting.
  • Effects of estrogen supplementation (OVXE) were evaluated.

Main Results:

  • OVX rats showed decreased plasma estrogen and increased HOMA-IR compared to SHAM rats.
  • Ovariectomy reduced PI3K and Akt expression in liver and skeletal muscle.
  • Akt1 reduction was observed in the liver, while Akt2 decreased in skeletal muscle.
  • Estrogen supplementation reversed these molecular and metabolic changes.

Conclusions:

  • Estrogen deficiency impairs insulin sensitivity, at least partly, by inhibiting PI3K/Akt signaling in liver and skeletal muscle.
  • Akt1 and Akt2 exhibit tissue-specific expression patterns and roles in estrogen-mediated insulin signaling.
  • Estrogen replacement therapy holds potential for managing insulin resistance associated with estrogen deficiency.